Skip to content
Subscriber Only
Business

Bayer’s Roundup Trial Delay Gives Time for Settlement Talks

  • Last scheduled case of the year is postponed in St. Louis
  • Move suggests negotiations on deal may be progressing: Analyst
Bayer Keeps Roundup Faith After Losing Second Trial on Cancer

Photographer: Daniel Acker/Bloomberg

Updated on

The last scheduled trial of the year over Bayer AG’s Roundup herbicide has been postponed at the request of both parties, indicating that talks toward a settlement may be progressing.

The delay to the trial in St. Louis, following two other postponements in August, gives the German drug and chemical giant breathing room to pursue negotiations over more than 18,000 claims that the weedkiller causes cancer -- which Bayer denies.